Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE)

• Published in: International journal of molecular sciences 2021-08, Vol.22 (15), p.8268
• Main Authors: Chen, Hsin-Yuan, Cheng, Wen-Pin, Chiang, Yi-Fen, Hong, Yong-Han, Ali, Mohamed, Huang, Tsui-Chin, Wang, Kai-Lee, Shieh, Tzong-Ming, Chang, Hsin-Yi, Hsia, Shih-Min
• Format: Article
• Language: English
• Subjects: Antioxidants; Antiproliferatives; Apoptosis; Autophagy; BAX protein; Bcl-2 protein; Bcl-x protein; Cancer; Cancer therapies; Caspase-3; Cell cycle; Cell proliferation; Chemotherapy; Cyclin D1; Cyclin-dependent kinase 4; Endometrial cancer; Endometrium; Extracellular signal-regulated kinase; Flow cytometry; hinokitiol; Inflammation; Lymphocytes B; Medical prognosis; Mutation; p53 Protein; Phagocytosis; Phosphorylation; Poly(ADP-ribose) polymerase; Proteins; reactive oxygen species; Ribose; Trends; Tumor cell lines; Tumor suppressor genes; Tumors; Western blotting
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22158268

Hinokitiol is a natural tropolone derivative that is present in the heartwood of cupressaceous plants, and has been extensively investigated for its anti-inflammatory, antioxidant, and antitumor properties in the context of various diseases. To date, the effects of hinokitiol on endometrial cancer (EC) has not been explored. The purpose of our study was to investigate the anti-proliferative effects of hinokitiol on EC cells. Cell viability was determined with an MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, and the quantification of apoptosis and reactive oxygen species (ROSs) was performed by using flow cytometry, while protein expression was measured with the Western blotting technique. Hinokitiol significantly suppressed cell proliferation through the inhibition of the expression of cell-cycle mediators, such as cyclin D1 and cyclin-dependent kinase 4 (CDK4), as well as the induction of the tumor suppressor protein p53. In addition, hinokitiol increased the number of apoptotic cells and increased the protein expression of cleaved-poly-ADP-ribose polymerase (PARP) and active cleaved-caspase-3, as well as the ratio of Bcl-2-associated X protein (Bax) to B-cell lymphoma 2 (Bcl-2). Interestingly, except for KLE cells, hinokitiol induced autophagy by promoting the accumulation of the microtubule-associated protein light chain 3B (LC3B) and reducing the sequestosome-1 (p62/SQSTM1) protein level. Furthermore, hinokitiol triggered ROS production and upregulated the phosphorylation of extracellular-signal-regulated kinase (p-ERK1/2) in EC cells. These results demonstrate that hinokitiol has potential anti-proliferative and pro-apoptotic benefits in the treatment of endometrial cancer cell lines (Ishikawa, HEC-1A, and KLE).